DUPI OLE - R668-AD-1225
Laufzeit: 01.01.2016 - 31.12.2018
imported
Kurzfassung
An open lable study of dupilumab in patients with atopic Dermatitis who participated in previous dupilumab clinical trials
Laufzeit: 01.01.2016 - 31.12.2018
An open lable study of dupilumab in patients with atopic Dermatitis who participated in previous dupilumab clinical trials